[1]
Yemineni Gopi et al. 2025. A RETROSPECTIVE ANALYSIS OF CARDIOTOXICITY WITH DOXORUBICIN AND TRASTUZUMAB IN BREAST CANCER HER-2 POSITIVE PATIENTS. The Bioscan. 20, 1 (Mar. 2025), 687–695. DOI:https://doi.org/10.63001/tbs.2025.v20.i01.pp687-695.